• SENSEX 77,928.15
    273.55 (+0.35%)
  • BANKNIFTY 57,147.50
    -58.40 (--0.10%)
  • Indo-MIM
    757.50 757.50(%)
  • Bajaj Finserv
    1,891.35 1,598.15(%)
  • Bajaj Finance
    1,067.05 1,102.45(%)
  • ICICI Bank
    1,423.00 1,187.55(%)
  • HDFC Bank
    758.00 1,020.35(%)
  • Adani Green
    1,350.10 767.00(%)
  • Reliance Industries
    1,298.00 1,611.20(%)
  • DLF
    652.05 489.30(%)
  • TBO Tek
    1,473.20 1,005.50(%)
  • Eicher Motors
    7,929.00 8,232.80(%)
  • Kalyan Jewellers
    649.00 649.00(%)
  • M & M
    3,325.00 3,840.00(%)
  • TVS Motor Co.
    4,219.00 4,219.00(%)
  • Infosys
    1,187.00 1,727.85(%)
  • Coforge
    1,763.70 1,988.90(%)
  • Jubilant Food.
    433.80 408.50(%)
  • Waaree Energies
    2,563.00 2,402.00(%)
  • Cholaman.Inv.&Fn
    1,758.65 1,299.80(%)
  • Redington
    338.20 338.20(%)
  • SBI
    1,030.00 1,234.80(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Indoco Remedies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 12579.0
  • ISIN : INE873D01024
216.69 -8 (-3.71%)
  • As on 30 Jul 2026 (EOD)

  • Today’s Low

    216.03

  • Today’s High

    222.90

  • Open

    222.90

  • Perv Close

    225.05

  • 52W Low

    162.19

  • 52W High

    332.20

Key Indicators

  • P/E(TTM)

    93.13

  • Mar.Cap (₹Cr.)

    2,000.13

  • Div & Yield %

    0.09

  • Book Value(₹)

    119.08

  • Debt-Equity Ratio

    -3.71

  • AGM Date

    30-Jul-2026

  • EPS

    2.33

  • P/E Ratio

    93.13

Financials Ratios

  • Debt-Equity Ratio

    0.47

  • Mar.Cap (₹Cr.)

    2,000.13

  • RONW (%)

    9.07

  • ROCE (%)

    10.76

Score Board

  • Equity (₹ in Cr.)

    18.46

  • BV (₹)

    119.10

  • Sales( ₹ in Cr.)

    1,633.54

  • NP (in Cr.)

    -3.53

  • NP Var(%)

    64.0

  • Div%

    10.0

  • CPS (₹)

    11.20

  • EPS (₹)

    -0.40

  • Traded Value (₹ in Lakhs)

    2,002.99

  • 52 Week High

    332.20

  • 52 Week Low

    162.19

  • Price BSE

    217.0

  • Price NSE

    217.00

  • Market Capital( in Cr.)

    2,002.99

  • P/C Ratio

    19.40

  • P/E Ratio

    -567.70

  • Price Vs.BV

    -0.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 1,518.19 1,790.81 1,666.69 1,539.72 1,240.30 1,105.99
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,518.19 1,790.81 1,666.69 1,539.72 1,240.30 1,105.99
Other Income 19.48 28.24 2.33 2.32 3.11 2.43
Stock Adjustments 32.04 14.70 -6.55 26.30 12.13 8.05
Total Income 1,569.71 1,833.75 1,662.47 1,568.34 1,255.54 1,116.47
EXPENDITURE :            
Raw Materials 475.72 561.15 514.74 483.05 366.20 338.48
Power and Fuel Cost 53.45 55.31 50.61 42.78 36.89 34.75
Employee Cost 368.74 350.55 321.15 294.95 272.88 255.32
Other Manufacturing Expenses 91.60 116.72 89.70 60.66 46.07 44.38
Selling and Administration Expenses 387.49 407.12 340.26 293.42 258.53 287.83
Miscellaneous Expenses 45.19 64.86 58.79 64.15 48.29 29.95
Employee Benefit Expenses 368.74 350.55 321.15 294.95 272.88 255.32
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,422.19 1,555.72 1,375.25 1,239.02 1,028.86 990.70
Operating Profit 147.50 278.02 287.22 329.32 226.69 125.77
Interest 56.63 36.81 25.03 14.14 22.22 26.25
Gross Profit 90.87 241.21 262.19 315.18 204.47 99.52
Depreciation 98.25 87.98 70.60 78.95 73.12 70.81
Profit Before Tax -7.38 153.23 191.59 236.23 131.35 28.71
Current Tax 0.00 32.77 55.20 93.23 38.47 3.86
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.36 3.81 -4.97 -11.52 0.48 0.60
Reported Net Profit -8.74 116.64 141.36 154.52 92.39 24.25
Extraordinary Items 1.15 8.49 -0.90 -0.31 -0.17 -0.19
Adjusted Net Profit -9.89 108.15 142.26 154.83 92.56 24.44
Adjustment below Net Profit -4.49 0.04 1.44 -5.33 -0.86 -2.41
P & L Balance brought forward 781.49 685.55 563.48 428.11 339.35 320.27
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 13.83 20.73 20.73 13.82 2.76 2.76
P & L Balance carried down 754.44 781.49 685.55 563.48 428.11 339.35
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 75.00 112.50 112.50 75.00 15.00
Dividend Per Share(Rs) 0.20 1.50 2.25 2.25 1.50 0.30
Earnings Per Share-Unit Curr -0.95 12.65 15.34 16.77 10.03 2.63
Earnings Per Share(Adj)-Unit Curr -0.95 12.65 15.34 16.77 10.03 2.63
Book Value 119.61 122.22 111.45 98.13 83.44 73.81
Book Value(Adj)-Unit Curr 119.61 122.22 111.45 98.13 83.44 73.81

Shareholding Pattern

  • Promoter Group

    58.86%

  • Public Share Holding

    41.00%

  • Custodian

    0.14%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 20,060,167 21.73 20,060,167 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 34,273,082 37.13 34,273,082 7
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 54,333,249 58.86 54,333,249 12
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,176,394 1.27 1,176,394 34
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 15,834,938 17.16 15,834,938 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 483,873 0.52 483,873 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 17,495,205 18.95 17,495,205 45
2] Non Institution
Bodies Corporate 2,416,033 2.62 2,416,033 154
Clearing Members 36,522 0.04 36,522 22
Directors of their Relatives 1,140,500 1.24 1,140,500 6
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 642,184 0.70 642,184 811
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 410,594 0.44 410,594 676
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,636,464 5.02 4,636,464 20
Individuals holding nominal share capital up to Rs. 1 lakh 10,761,547 11.66 10,529,347 30,682
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 151,099 0.16 151,099 1
Sub Total 20,345,251 22.04 20,113,051 32,399
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 129,900 0.14 129,900 1
Total Shares held by Custodians and against which Depository Receipts have been issued 129,900 0.14 129,900 1
Grand Total ( A + B + C ) 92,303,605 100.00 92,071,405 32,457

Company Background

Indoco Remedies LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Indoco Remedies Ltd
  • BSE Code : 12579.0
  • ISIN : INE873D01024

  • Incorporation Year

    1947

  • Registered Office

    Indoco House 166 C S T Road
    Santacruz (East) Kalina, Mumbai,
    Maharashtra-400098

  • Telephone

    91-022-26541851-55

  • FAX

    91-022-26520787

  • Chairman

    Suresh G Kare

  • Managing Director

    Suresh G Kare

  • Company Secretary

  • Auditor

    Gokhale & Sathe

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Indoco Remedies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Indoco Remedies 217.00 1,536.67 1,518.19 19.12 2.68
Abbott India 27,566.00 7,217.19 6,929.05 37.74 43.78
Astrazeneca Phar 8,090.05 2,304.07 2,275.58 107.85 27.86
P & G Health Ltd 6,502.50 944.52 934.17 33.02 71.75
Glaxosmi. Pharma 2,609.65 3,932.76 3,790.20 43.69 58.17
Cipla 1,466.00 20,102.60 18,979.95 38.53 13.88
Amrutanjan Healt 518.30 469.50 451.82 25.88 21.89
Fermenta Biotec. 465.55 474.15 450.25 21.32 18.77
Bliss GVS Pharma 454.10 773.53 729.81 49.74 12.51
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 33.64 19.52 3.94 23.52 6.77